Stock Rating Downgrade
In recent days the Value Trend Rating for Neogenomics Inc (NASDAQ: NEO) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
Neogenomics Inc (NASDAQ: NEO) stock declined modestly by -1.7% on 4/19/24. The stock closed at $13.53. Trading volume in this decline was normal. The stock has performed in line with the market over the last nine months and has declined -6.8% during the last week.
Current PriceTarget Research Rating
NEO’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Neogenomics has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Neogenomics has a poor Appreciation Score of 24 but a slightly positive Power Rating of 63, triggering the Negative Value Trend Rating.
Be the first to comment